JUBLPHARMA — Jubilant Pharmova Share News
0.000.00%
- IN₹152.72bn
- IN₹174.03bn
- IN₹82.80bn
Brief: Jubilant Pharmova Names Priyavrat Bhartia As MD
India's Jubilant Pharmova slumps after posting Q4 loss
Brief: Jubilant Pharmova Dividend 5 Rupees Per Share
Brief: India's Jubilant Pharmova Posts March-Quarter Consol Net Loss
Indian fast-food chain operators face weak demand, investors should wait - HDFC Securities
Brief: Jubilant Pharmova Says As Per US FDA inspection Nanjangud Facility In Compliance With Manufacturing Practices
Jubilant's Popeyes ramp-up in India to challenge KFC - brokerage
India's Jubilant Pharma tumbles after reporting loss in Q3
Brief: India's Jubilant Pharmova Posts Dec-Quarter Consol Loss Vs Profit
India's Jubilant Pharmova sees worst day in near a month on USFDA observations
Brief: Jubilant Pharmova Says FDA Issued 8 Observations After Inspection Of Nanjangud Facility
PREVIEW: India's Domino's franchisee Jubilant edges higher ahead of earnings
Brief: India's Jubilant Pharmova Sept-Quarter Net Profit Falls
Brief: Jubilant Pharmova Says USFDA Completes Audit Of Its Solid Dosage Manufacturing Facility
Brief: India's Jubilant Pharmova Qtrly Profit Falls
Brief: Jubilant Pharmova Gets ANDA Approval For Doxepin Hydrochloride Capsules
India's Jubilant Pharmova plunges as Dec-qtr profit tanks 84%
Brief: India's Jubilant Pharmova Dec-Quarter Consol Net Profit Falls
Brief: India's Jubilant Pharmova Reports Higher June Quarter Consol Net Profit